Does POLATUZUMAB VEDOTIN-PIIQ Cause Diffuse large b-cell lymphoma recurrent? 81 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with POLATUZUMAB VEDOTIN-PIIQ. This represents 2.6% of all adverse event reports for POLATUZUMAB VEDOTIN-PIIQ.
81
Reports of Diffuse large b-cell lymphoma recurrent with POLATUZUMAB VEDOTIN-PIIQ
2.6%
of all POLATUZUMAB VEDOTIN-PIIQ reports
7
Deaths
5
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From POLATUZUMAB VEDOTIN-PIIQ?
Of the 81 reports, 7 (8.6%) resulted in death, 5 (6.2%) required hospitalization.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POLATUZUMAB VEDOTIN-PIIQ. However, 81 reports have been filed with the FAERS database.
What Other Side Effects Does POLATUZUMAB VEDOTIN-PIIQ Cause?
Disease progression (753)
Off label use (484)
Death (367)
Covid-19 (202)
Neutropenia (160)
Pyrexia (119)
Drug ineffective (118)
No adverse event (109)
Blood lactate dehydrogenase increased (108)
Febrile neutropenia (107)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which POLATUZUMAB VEDOTIN-PIIQ Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
POLATUZUMAB VEDOTIN-PIIQ vs POLIDOCANOL
POLATUZUMAB VEDOTIN-PIIQ vs POLYETHYLENE GLYCOL
POLATUZUMAB VEDOTIN-PIIQ vs POLYETHYLENE GLYCOL 3350
POLATUZUMAB VEDOTIN-PIIQ vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM
POLATUZUMAB VEDOTIN-PIIQ vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM\SODIUM